NAMA and thyroid gland carcinoma: Sedaghati (Sedaghati and Kebebew 2019) summarized the dysregulated and functional LncRNAs in thyroid cancer, including 28 upregulated LncRNAs, such as ANRIL, BANCR, H19, HOTAIR, MALAT1, and NEAT1, and 22 downregulated LncRNAs, including GAS5, NAMA, PTCSC2, and PTCSC3.